1. Home
  2. INNV vs CTKB Comparison

INNV vs CTKB Comparison

Compare INNV & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnovAge Holding Corp.

INNV

InnovAge Holding Corp.

HOLD

Current Price

$4.99

Market Cap

485.4M

Sector

Health Care

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.99

Market Cap

433.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INNV
CTKB
Founded
2007
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
485.4M
433.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
INNV
CTKB
Price
$4.99
$4.99
Analyst Decision
Sell
Hold
Analyst Count
2
4
Target Price
$5.00
$5.88
AVG Volume (30 Days)
242.5K
1.8M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$884,662,000.00
$196,828,000.00
Revenue This Year
$11.18
N/A
Revenue Next Year
$9.58
$5.62
P/E Ratio
N/A
N/A
Revenue Growth
12.48
N/A
52 Week Low
$2.60
$2.37
52 Week High
$6.26
$7.30

Technical Indicators

Market Signals
Indicator
INNV
CTKB
Relative Strength Index (RSI) 48.23 49.02
Support Level $4.94 $5.15
Resistance Level $5.21 $5.50
Average True Range (ATR) 0.44 0.37
MACD -0.02 -0.09
Stochastic Oscillator 17.42 5.95

Price Performance

Historical Comparison
INNV
CTKB

About INNV InnovAge Holding Corp.

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: